Charleston Area Medical Center Inc

CAMC TECHNICAL DEBT UPGRADES AND CYBERSECURITY TECHNOLOGY - CHARLESTON AREA MEDICAL CENTER (CAMC) SEEKS $15,000,000 IN COMMUNITY PROJECT FUNDING/CONGRESSIONALLY DIRECTED SPENDING (CPF/CDS) UNDER HRSA-26-107 TO IMPLEMENT A FACILITY INFRASTRUCTURE MODERNIZATION AND CYBERSECURITY PROTECTION PROJECT ACROSS ITS SOUTH REGION, SERVING SIX HOSPITALS AND MORE THAN 150 AMBULATORY CARE SITES IN CHARLESTON, WEST VIRGINIA, AND SURROUNDING COMMUNITIES. THE PURPOSE OF THIS PROJECT IS TO MODERNIZE AGING FACILITY INFRASTRUCTURE SYSTEMS THAT ARE CRITICAL TO THE SAFE AND RELIABLE DELIVERY OF PATIENT CARE. CAMC’S CURRENT INFRASTRUCTURE, MUCH OF WHICH IS MORE THAN 10 YEARS OLD, EXPERIENCES RECURRING OUTAGES THAT DISRUPT CLINICAL OPERATIONS, DELAY ACCESS TO PATIENT INFORMATION, AND INCREASE RISKS TO PATIENT SAFETY. THESE SYSTEMS SUPPORT ESSENTIAL HEALTHCARE FUNCTIONS, INCLUDING PATIENT RECORDS, DIAGNOSTIC IMAGING, LABORATORY SERVICES, AND MEDICATION MANAGEMENT. THE PROPOSED PROJECT WILL UPGRADE CORE FACILITY INFRASTRUCTURE, INCLUDING NETWORK CABLING, ELECTRICAL PATHWAYS SUPPORTING CLINICAL SYSTEMS, AND INSTALLATION OF CYBERSECURITY PROTECTION TECHNOLOGIES. KEY ACTIVITIES INCLUDE REPLACING OUTDATED NETWORK ELECTRONICS, IMPLEMENTING NETWORK SEGMENTATION TO PROTECT CRITICAL CARE FUNCTIONS, INSTALLING FIREWALL SYSTEMS TO SAFEGUARD CLINICAL OPERATIONS, AND DEPLOYING SECURE BACKUP AND RECOVERY SYSTEMS TO ENSURE CONTINUITY OF CARE. THIS PROJECT WILL BE IMPLEMENTED AS AN ALTERATION/RENOVATION WITH EQUIPMENT INITIATIVE, CONSISTENT WITH HRSA CPF/CDS CONSTRUCTION GUIDANCE. IMPROVEMENTS WILL DIRECTLY SUPPORT HEALTHCARE SERVICE DELIVERY BY STRENGTHENING INFRASTRUCTURE RELIABILITY AND PROTECTING SENSITIVE PATIENT DATA. CAMC WILL ALIGN ALL CYBERSECURITY ENHANCEMENTS WITH THE NIST CYBERSECURITY FRAMEWORK (CSF 2.0), INCORPORATING THE CORE FUNCTIONS OF GOVERN, IDENTIFY, PROTECT, DETECT, RESPOND, AND RECOVER. THIS APPROACH ENSURES A COMPREHENSIVE, RISK-BASED STRATEGY TO PROTECT HEALTHCARE SYSTEMS, MAINTAIN OPERATIONAL CONTINUITY, AND RESPOND EFFECTIVELY TO CYBERSECURITY THREATS. THE PROJECT IS EXPECTED TO SIGNIFICANTLY IMPROVE HEALTHCARE DELIVERY OUTCOMES, INCLUDING REDUCING SYSTEM DOWNTIME BY AT LEAST 50 PERCENT, ACHIEVING 99.9 PERCENT UPTIME ACROSS FACILITIES, AND ENSURING THAT 100 PERCENT OF CRITICAL SYSTEMS ARE SUPPORTED BY VALIDATED BACKUP AND RECOVERY CAPABILITIES. THESE IMPROVEMENTS WILL DIRECTLY ENHANCE PATIENT SAFETY, REDUCE DELAYS IN CARE, AND IMPROVE ACCESS TO RELIABLE HEALTHCARE SERVICES IN THE REGION. BY STRENGTHENING FACILITY INFRASTRUCTURE AND SAFEGUARDING CRITICAL SYSTEMS, THIS PROJECT SUPPORTS HRSA’S MISSION TO IMPROVE ACCESS TO QUALITY HEALTHCARE, PARTICULARLY FOR MEDICALLY UNDERSERVED AND VULNERABLE POPULATIONS SERVED BY CAMC.

COMMUNITY PROJECT FUNDING/CONGRESSIONALLY DIRECTED SPENDING - CONSTRUCTION - CHARLESTON AREA MEDICAL CENTER SEEKS FUNDING FOR THE CONSTRUCTION OF A STATE-OF-THE-ART OUTPATIENT CLINIC TWO-STORY 30,000 SF BUILDING ON THE CAMPUS OF THE ONLY LEVEL 1 TRAUMA HOSPITAL IN SOUTHERN WV. THIS FACILITY WILL SUPPORT A TEAM-BASED CARE MODEL WITH ALL THE NEUROSCIENCE SPECIALISTS IN ONE LOCATION. CHARLESTON LACKS A DEDICATED NEUROSCIENCES INSTITUTE, LEADING TO LIMITED ACCESS TO SPECIALIZED CARE FOR NEUROLOGICAL DISORDERS; REGIONAL DATA SHOWS A 15% INCREASE IN NEUROLOGICAL CASES OVER THE PAST FIVE YEARS. WE ANTICIPATE ESTABLISHING A STATE-OF-THE-ART NEUROSCIENCE INSTITUTE AT CHARLESTON AREA MEDICAL CENTER TO PROVIDE COMPREHENSIVE CARE, ADVANCED DIAGNOSTICS, AND CUTTING-EDGE TREATMENTS FOR NEUROLOGICAL CONDITIONS. WE WILL PARTNERSHIP WITH CHARLESTON UNIVERSITY FOR RESEARCH COLLABORATION AND TALENT PIPELINE. COLLABORATION WITH NEUROTECH INC. TO PROVIDE CUTTING-EDGE NEUROLOGICAL EQUIPMENT AND ASSISTED WITH THE MOST ADVANCED TECHNOLOGY. IN ADDITION, WE WILL ALLY WITH LOCAL HEALTHCARE PROVIDERS FOR PATIENT REFERRALS AND INTEGRATED CARE. IN CONCLUSION, WE PROJECT TO IMPROVE PATIENT OUTCOMES MEASURED BY A 25% REDUCTION IN NEUROLOGICAL DISORDER COMPLICATIONS AS WELL AS ENHANCED RESEARCH OUTPUT TRACKED THROUGH A 30% INCREASE IN PUBLISHED STUDIES AND CLINICAL TRIALS.